Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mistral Capital Management Limited operates as a pharmaceutical company specializing in the supply and promotion of pharmaceuticals and medical devices for hospitals. Since 2013 it has engaged in contract manufacturing for products used in oncology, hematology, multiple sclerosis, osteoporosis and other indications. Its portfolio includes antimicrobials, dietary supplements and medical devices. The company aims to provide affordable access to quality treatments for socially significant diseases across Europe, Asia (notably Ukraine/Kazakhstan/Uzbekistan), Africa and Eurasian Economic Union countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mistral Wealth Management.